NH
Narayana Hrudayalaya Ltd. (NH) Stock Analysis
Narayana Hrudayalaya Ltd. is a leading Indian hospital chain providing affordable cardiac and multi-specialty healthcare across India and select international locations. It operates large hospitals with high surgical volumes and insurance tie-ups. Bed expansion and clinical outcomes underpin brand strength. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹1,719.40
-0.01% 1W | -3.80% 52W
Market Cap
34.9k CR
P/E Ratio
42.5
52W High
₹2093.3
52W Low
₹1589
Div. Yield
0.26%
Beta
0.1
50 DMA
₹1836.5
200 DMA
₹1840.7
Profit Margin
9%
Inst. Own.
12.9%
⚡ APPROACHING SUPPORT
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,233 | 1,305 | 1,204 | 1,246 | 1,306 | 1,367 | 1,335 | 1,475 | 1,507 | 1,644 | 2,151 | 2,594 | 2,684 |
| Expenses | 963 | 997 | 925 | 955 | 1,004 | 1,058 | 1,027 | 1,118 | 1,171 | 1,243 | 1,786 | 2,086 | 2,216 |
| Operating Profit | 271 | 308 | 279 | 291 | 302 | 309 | 307 | 358 | 337 | 401 | 365 | 508 | 468 |
| OPM % | 22% | 24% | 23% | 23% | 23% | 23% | 23% | 24% | 22% | 24% | 17% | 20% | 17% |
| Other Income | 15 | 18 | 18 | 26 | 24 | 23 | 18 | 20 | 24 | 24 | -29 | 25 | 35 |
| Interest | 21 | 23 | 25 | 28 | 34 | 35 | 37 | 41 | 45 | 42 | 65 | 91 | 87 |
| Depreciation | 59 | 55 | 63 | 65 | 61 | 65 | 70 | 82 | 84 | 87 | 122 | 154 | 156 |
| Profit before tax | 206 | 248 | 209 | 225 | 231 | 232 | 219 | 254 | 232 | 296 | 149 | 288 | 260 |
| Tax % | 11% | 9% | 10% | 15% | 13% | 14% | 12% | 22% | 15% | 13% | 15% | 22% | 20% |
| Net Profit | 184 | 227 | 188 | 191 | 202 | 199 | 193 | 197 | 197 | 258 | 127 | 224 | 207 |
| EPS in Rs | 9.00 | 11.09 | 9.20 | 9.33 | 9.85 | 9.72 | 9.44 | 9.65 | 9.62 | 12.64 | 6.20 | 10.96 | 10.14 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,364 | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 4,890 | 5,483 | 7,896 | 9,072 |
| Expenses | 1,236 | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,722 | 4,185 | 6,255 | 7,330 |
| Operating Profit | 128 | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,168 | 1,298 | 1,641 | 1,742 |
| OPM % | 9% | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 24% | 24% | 21% | 19% |
| Other Income | 6 | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 73 | 80 | 37 | 56 |
| Interest | 45 | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 163 | 266 | 285 |
| Depreciation | 68 | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 241 | 278 | 448 | 520 |
| Profit before tax | 21 | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 888 | 936 | 964 | 993 |
| Tax % | 71% | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | 16% | 16% | |
| Net Profit | -19 | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 791 | 806 | 817 |
| EPS in Rs | -0.84 | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.66 | 39.42 | 39.94 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% | 12% | 11% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 20.0% | 25.0% | 17.0% |
| Profit CAGR | 12.0% | 155.0% | 42.0% |
Shareholding Pattern
Promoters63.85%
FIIs10.49%
DIIs7.76%
Public17.29%
Promoters63.27%
FIIs11.10%
DIIs7.91%
Public17.09%
Promoters63.27%
FIIs9.98%
DIIs9.14%
Public16.98%
Promoters63.27%
FIIs9.40%
DIIs9.05%
Public17.65%
Promoters63.27%
FIIs9.01%
DIIs10.68%
Public16.42%
Promoters63.85%
FIIs10.36%
DIIs14.14%
Public11.01%
Promoters63.85%
FIIs10.91%
DIIs9.51%
Public15.12%
Promoters63.85%
FIIs9.66%
DIIs8.52%
Public17.34%
Promoters63.27%
FIIs9.98%
DIIs9.14%
Public16.98%
Promoters63.27%
FIIs9.01%
DIIs10.68%
Public16.42%
NH
Holdings Analysis
Key strengths & risk signals
59
Overall
69
Fundamental
50
Technical
Risks (4)
OVERVALUED! PEG of 4.29 means expensive relative to growth rate.
WEAK POSITION! Current price (1719.4) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.0% (1 week), 7.1% (1 month), 15.3% (3 months).
BEARISH TREND! 50-day average (1836.5) is below 200-day average (1840.7) - negative signal.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
LOW VOLATILITY! Beta of 0.10 - stable stock, less market risk.
APPROACHING OVERSOLD! RSI at 38.4 - watch for reversal.
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 200,181 vs down days: 192,624. Ratio: 1.04x
Fundamental & Technical Analysis
59Overall
69Fundamental
50Technical
Fundamental Breakdown
Growth Quality
23/30
Revenue CAGR: 20.5% (EXCELLENT, 15/15). Profit CAGR: 9.9% (MODERATE, 8/15).
Profit Margin
3/10
LOW MARGIN! 9.0% profit margin - thin profits.
PEG Valuation
0/10
OVERVALUED! PEG of 4.29 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.26% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 12.45% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (1836.5) is below 200-day average (1840.7) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (1719.4) is below both moving averages.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
3/10
WEAK YEAR! Stock declined 3.8% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 200,181 vs down days: 192,624. Ratio: 1.04x
RSI
4/5
APPROACHING OVERSOLD! RSI at 38.4 - watch for reversal.
52W Range
2/5
LOWER HALF! Trading at 25.9% of 52W range - weakness visible.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.0% (1 week), 7.1% (1 month), 15.3% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.10 - stable stock, less market risk.
NH
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-10 | Concall PDF | |
| Q4FY262026-06-02 | Concall PDF | |
| Q3FY262026-02-24 | Concall PDF | |
| Q2FY262025-11-24 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NH | ₹1,719.40 | 42.5 | 9.0% | 20.5% | 9.9% | -3.8% | 59 | APPROACHING SUPPORT | +5.3% | -7.5% | +78.0% | +3.5% |
| MEDANTA | ₹1,240.00 | 60 | 11.9% | 17.2% | 19.5% | -6.7% | 64 | BREAKDOWN | -0.2% | +10.2% | +26.5% | +12.5% |
| KIMS | ₹685.60 | 134.4 | 4.8% | 21.3% | -10.5% | -4.3% | 58 | BREAKDOWN | -47.2% | -2.4% | +35.3% | +9.8% |
| FORTIS | ₹736.50 | 53.1 | 11.0% | 13.3% | 21.0% | -31.2% | 61 | BREAKDOWN | +2.3% | +0.2% | +17.5% | +7.6% |
| ASTERDM | ₹674.40 | 109.3 | 6.5% | 15.7% | -3.0% | -2.8% | 56 | BREAKDOWN | -81.2% | -88.5% | +21.6% | +10.9% |
| MAXHEALTH | ₹846.00 | 56.7 | 16.7% | 22.4% | 9.3% | -28.7% | 55 | BREAKDOWN | +4.9% | -5.6% | +16.7% | +10.4% |
| APOLLOHOSP | ₹7,890.00 | 54.3 | 7.9% | 14.8% | 33.3% | -0.2% | 63 | BREAKDOWN | +34.2% | +9.7% | +20.6% | +6.6% |
| RAINBOW | ₹1,248.90 | 44.4 | 15.7% | 13.1% | 9.7% | -7.6% | 64 | BOUNCE FROM SUPPORT | +13.3% | -21.3% | +33.2% | +2.2% |
Data from TradeAlone · Updated daily
